We advise leading pharmaceutical companies on the evaluation and divestment of drug manufacturing and R&D sites. We are also experts in licensing products, compounds, IP and technologies.
Subscribe to receive our latest sector-specific research on M&A activity and fundraisings:
Find out more View All
I commend and thank our on-site team members for their hard work and commitment to this project, which is a major opportunity for the Toulouse site. I would also like to express my appreciation to all the stakeholders - elected officials, authorities, associations, members of the scientific community - whose invaluable support has made this...